Drug manufacturer AbbVie recently replied to Louisiana’s request for summary judgement and defended its own such request in its ongoing [...] …
Year: 2024
Prescribers who work in federally qualified health centers (FQHCs) believe the 340B program helps their organizations and patients—even if they [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340B INDUSTRY LEADER SPOTLIGHT
Brandon Patchett, Senior Director of Pharmacy-Clinical Services, AIDS Healthcare Foundation
Q: Where did you grow up?
I grew up in a small town, Frankfort, Indiana, raised in the country and surrounded by farmland. While my family would have liked me to carry on the family farming tradition and become a farmer, my personal Dad joke is that I eventually became a “Pharm”-acist instead.
Q: Where did you go
…
SPONSORED CONTENT
TIP: Improve capture rates to reach your full 340B savings potential.
From changing compliance mandates to the
Despite its overwhelming support from the state legislature, Virginia Gov. Glenn Youngkin (R) late yesterday amended a 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) on Monday announced Chantelle Britton as its next Office of Pharmacy Affairs (OPA) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
South Carolina last week became the twenty-third state to introduce a bill this legislative session to bar drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district court has transferred drugmaker AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law to a judge who [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmacy benefit managers (PBMs) and insurers operating in Oregon are barred from restricting 340B drug dispensing or limiting the number [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...] …
